Bile pigment pharmacokinetics and absorption in the rat: therapeutic potential for enteral administration
about
Mechanisms of interleukin-22's beneficial effects in acute pancreatitisEffect of bile pigments on the compromised gut barrier function in a rat model of bile duct ligationEndogenous Tetrapyrroles Influence Leukocyte Responses to Lipopolysaccharide in Human Blood: Pre-Clinical Evidence Demonstrating the Anti-Inflammatory Potential of Biliverdin.Biliverdin protects against liver ischemia reperfusion injury in swine.Reduced circulating oxidized LDL is associated with hypocholesterolemia and enhanced thiol status in Gilbert syndromeIn vitro DNA-damaging effects of intestinal and related tetrapyrroles in human cancer cells.Bilirubin and related tetrapyrroles inhibit food-borne mutagenesis: a mechanism for antigenotoxic action against a model epoxide.Therapeutic approaches to limit hemolysis-driven endothelial dysfunction: scavenging free heme to preserve vasculature homeostasis.Circulating bilirubin and defense against kidney disease and cardiovascular mortality: mechanisms contributing to protection in clinical investigations.Heme Oxygenases in Cardiovascular Health and Disease.Biliverdin modulates the expression of C5aR in response to endotoxin in part via mTOR signaling.Endogenously elevated bilirubin modulates kidney function and protects from circulating oxidative stress in a rat model of adenine-induced kidney failure.Extracellular and intracellular anti-mutagenic effects of bile pigments in the Salmonella typhimurium reverse mutation assay.Hyperbilirubinemia modulates myocardial function, aortic ejection, and ischemic stress resistance in the Gunn rat.Haem catabolism: a novel modulator of inflammation in Gilbert's syndrome.Unconjugated bilirubin inhibits collagen induced platelet activation.Mildly elevated unconjugated bilirubin is associated with reduced platelet activation-related thrombogenesis and inflammation in Gilbert's syndrome.In vitro antioxidant capacity and antigenotoxic properties of protoporphyrin and structurally related tetrapyrroles.
P2860
Q26766654-6F5B8B43-18E4-44E6-89F4-C19F9FF36A75Q28539326-93E68933-C80C-4304-9670-F9800C196573Q34093709-629323B0-C40C-4022-B076-C90174E1C630Q34905192-68508377-C321-4443-B995-7C6D5061D913Q36041536-2D201D2C-9A3E-45B7-9672-3FE189013C2BQ36602357-44296384-D361-4E88-A724-1D47FF0E0979Q37267060-6EFF6A34-8940-4A79-A476-E1E70ABF1C58Q38115527-7F350E96-DEAE-4628-963C-3EB4182D9137Q38206770-FC693695-C920-4E49-B6C8-30BE86BD60FFQ38823562-C026C7C3-BD55-4793-A9C3-108C448A10A1Q38996518-93F6D851-35C5-46F2-A4DC-96392E2C3D0AQ40395687-A971BB9B-C90F-4AC8-A5D8-002E2B3D67BAQ42087685-8AEC8208-E7E1-4092-A399-E7D932573E77Q43578671-EE993E60-FA6E-47F0-8AB6-408616FD8488Q46036068-BB36188D-6A6F-41B6-80C5-D1FCFA0AF048Q46202266-5345515E-E3D1-4083-9F35-7A3B9544696AQ48116667-D5C6B070-22F2-4FD1-8971-687C7FDD9876Q50025304-45599D94-C7B5-46FD-9AE6-2E178D66EE07
P2860
Bile pigment pharmacokinetics and absorption in the rat: therapeutic potential for enteral administration
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Bile pigment pharmacokinetics ...... ial for enteral administration
@ast
Bile pigment pharmacokinetics ...... ial for enteral administration
@en
type
label
Bile pigment pharmacokinetics ...... ial for enteral administration
@ast
Bile pigment pharmacokinetics ...... ial for enteral administration
@en
prefLabel
Bile pigment pharmacokinetics ...... ial for enteral administration
@ast
Bile pigment pharmacokinetics ...... ial for enteral administration
@en
P2093
P2860
P1476
Bile pigment pharmacokinetics ...... ial for enteral administration
@en
P2093
A C Bulmer
J S Coombes
J T Blanchfield
R G Fassett
S M Taylor
P2860
P304
P356
10.1111/J.1476-5381.2011.01413.X
P407
P577
2011-12-01T00:00:00Z